CALGARY - A University of Calgary researcher has won a major U.S. grant to develop a vaccine against bacterial diseases that terrorists could use as a biological weapon.
Dr. Donald Woods has been awarded $1.7 million to study and test vaccines against two diseases - glanders and melioidosis - that the U.S. Centres for Disease Control and Prevention considers potential bioterrorism agents.
"It's easy to grow them in the lab. It would probably be easy to disperse them," said Woods, the Canada research chair in microbiology. "There is a very real threat, they could be used."
Woods hopes to develop a vaccine to stop the diseases from spreading in humans and animals.
The funding came from the U.S. National Institutes of Health.
Glanders is a bacterial disease that typically infects horses, although it can also be transmitted to humans.
The disease was allegedly spread among horses during the First World War to disrupt transportation.
Melioidosis, which is closely related to glanders, has affected people in Southeast Asia.
Both diseases kill about half of their victims.
Woods, who has been studying the two diseases for 20 years, is focusing his current research on glanders and believes the two illnesses are so closely related a vaccine for one would likely be effective against the other.
His research team has developed 12 candidates for a vaccine and will begin testing them on smaller animals before horses.
Dr. Richard Moore, a researcher who is working on the project, said the two diseases aren't likely to be the top choices for a biological weapon, but they are a potential threat.
"They (the U.S. government) wants this in their arsenal," he said.
� Calgary Herald 2008
Posts: 590 | From Canada | Registered: Oct 2007
| IP: Logged |
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/